Memorial Sloan Kettering Commack (Consent and Follow-Up)

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer2 trials
• Childhood cancers1 trial
• Kidney cancer1 trial
• Lung cancer1 trial
• Mesothelioma1 trial
• Sarcoma1 trial

Phase

• Phase 11 trial
• Phase 1/21 trial
• Phase 21 trial

Status

• Active, not recruiting2 trials
• Recruiting2 trials
• Completed1 trial

Lead sponsor

• Memorial Sloan Kettering Cancer Center5 trials

Running trials

• Active, not recruiting

  Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin

  NCT02414269· Phase 1/2· Memorial Sloan Kettering Cancer Center· Source

• Recruiting

  Kidney Cancer DNA Registry

  NCT02087852· Memorial Sloan Kettering Cancer Center· Source

  Contact: Jonathan Coleman, MD

• Active, not recruiting

  ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis

  NCT01815359· Phase 2· Memorial Sloan Kettering Cancer Center· Source

• Recruiting

  Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma

  NCT00579566· Memorial Sloan Kettering Cancer Center· Source

  Contact: Samuel Singer, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Kidney cancer1 recruiting
• Sarcoma1 recruiting

Closed trials

• Completed

  Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management

  NCT02199236· Phase 1· Memorial Sloan Kettering Cancer Center· Source